PMID: 7536930Apr 11, 1995Paper

B-cell activation by crosslinking of surface IgM or ligation of CD40 involves alternative signal pathways and results in different B-cell phenotypes

Proceedings of the National Academy of Sciences of the United States of America
H W WortisD C Parker

Abstract

Treatment of small resting B cells with soluble F(ab')2 fragments of anti-IgM, an analogue of T-independent type 2 antigens, induced activation characterized by proliferation and the expression of surface CD5. In contrast, B cells induced to proliferate in response to thymus-dependent inductive signals provided by either fixed activated T-helper 2 cells or soluble CD40 ligand-CD8 (CD40L) recombinant protein displayed elevated levels of CD23 (Fc epsilon II receptor) and no surface CD5. Treatment with anti-IgM and CD40L induced higher levels of proliferation and generated a single population of B cells coexpressing minimal amounts of CD5 and only a slight elevation of CD23. Anti-IgM- but not CD40L-mediated activation was highly sensitive to inhibition by cyclosporin A and FK520. Sp-cAMPS, an analogue of cAMP, augmented CD40L and suppressed surface IgM-mediated activation. Taken together these results are interpreted to mean that there is a single population of small resting B cells that can respond to either T-independent type 2 (surface IgM)- or T-dependent (CD40)-mediated activation. In response to different intracellular signals these cells are induced to enter alternative differentiation pathways.

References

Apr 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·A D BeyersA F Williams
May 7, 1992·Nature·R J ArmitageC R Maliszewski
Apr 1, 1992·Immunology Today·S L Schreiber, G R Crabtree
Jan 1, 1992·Annual Review of Immunology·N H Sigal, F J Dumont
Jan 1, 1990·Annual Review of Immunology·D H Conrad
May 1, 1989·European Journal of Immunology·A S FreedmanL M Nadler
Apr 1, 1994·European Journal of Immunology·A C LankesterR A van Lier
Jun 1, 1994·European Journal of Immunology·S ZupoM Ferrarini
Jan 1, 1994·European Journal of Immunology·J Hasbold, G G Klaus
Jul 1, 1994·European Journal of Immunology·A TarakhovskyK Rajewsky
Mar 1, 1995·International Immunology·M TeutschH W Wortis
Feb 1, 1993·Immunology Today·G HaughtonS H Clarke
Jul 1, 1993·The Journal of Experimental Medicine·S SaelandJ Banchereau
Jan 1, 1994·Annual Review of Immunology·J C CambierM R Clark
Jan 1, 1993·European Journal of Immunology·K Kawakami, D C Parker
Feb 1, 1993·Immunology Today·L A Herzenberg, A B Kantor
Apr 1, 1993·The Journal of Experimental Medicine·A C Lalmanach-GirardT L Rothstein

❮ Previous
Next ❯

Citations

Jun 10, 1998·Springer Seminars in Immunopathology·N RameshR S Geha
Apr 9, 2008·Journal of Hepato-biliary-pancreatic Surgery·Hiroto EgawaKazue Ozawa
Oct 1, 1996·Immunology Today·M A Borrello, R P Phipps
Jun 1, 1996·Current Opinion in Immunology·T L Rothstein
Oct 7, 2009·Immunology and Cell Biology·Mark N Cruickshank, Daniela Ulgiati
Feb 24, 2007·Nature Reviews. Immunology·Kenneth Dorshkind, Encarnacion Montecino-Rodriguez
Mar 2, 2002·Immunology·Kirk S HinkleyJames E Riggs
Mar 25, 2009·Proceedings of the National Academy of Sciences of the United States of America·Brandt L EsplinPaul W Kincade
Oct 2, 2013·Proceedings of the National Academy of Sciences of the United States of America·Jason PereraHaochu Huang
Oct 1, 1996·Proceedings of the National Academy of Sciences of the United States of America·J S AndersonH H Wortis
May 17, 2000·The Journal of Experimental Medicine·U D BajpaiH H Wortis
Oct 2, 1998·Tissue Antigens·M RöselM Zöller
Apr 5, 1997·Annals of the New York Academy of Sciences·S K Datta, A Kaliyaperumal
May 23, 1998·Annual Review of Immunology·A Henderson, K Calame
Feb 28, 2002·Annual Review of Immunology·Robert Berland, Henry H Wortis
Jul 1, 2004·Arthritis Research & Therapy·Sara A Johnson, John C Cambier
Sep 25, 2010·Seminars in Cancer Biology·Anders RosénRichard Rosenquist
Jul 14, 2010·Best Practice & Research. Clinical Haematology·M T S BertilaccioF Caligaris-Cappio
Apr 25, 2015·Annals of the New York Academy of Sciences·Kyoko HayakawaRichard R Hardy
Dec 2, 2008·Autoimmunity Reviews·Ali Dalloul
Nov 19, 2013·European Journal of Immunology·Branislav KrljanacFalk Weih
May 8, 2001·American Journal of Clinical Pathology·J J TiesingaG Inghirami
Apr 12, 2016·Frontiers in Immunology·Verena Katharina RakerKerstin Steinbrink
Mar 18, 1999·The American Journal of Pathology·T N FredricksonJ W Hartley
Apr 4, 2015·Cellular and Molecular Life Sciences : CMLS·Jason Perera, Haochu Huang

❮ Previous
Next ❯

Related Concepts

Related Feeds

B cell Activation

B cell activation is initiated by the ligation of the B cell receptor with antigen and ultimately results in the production of protective antibodies against potentially pathogenic invaders. Here is the latest research.